Delivery Order SPE2D021D0004-SPE2D024F0368

Award Date 7/11/24
Potential Completion Date 3/5/25
Potential Value $1.1K
Federal Agency
Medical Supply Chain
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Fixed Price with Economic Price Adjustment
Place of Performance
Park Ridge, IL 60068, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $1,112.95 firm fixed-price delivery order is for the supply of Varicella Virus Vaccine to support the medical needs of military healthcare facilities. This contract is not associated with any set-aside designations. DMS Pharmaceutical Group Inc. holds a $499,999,999 Indefinite Delivery Contract...
The U.S. government's Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract valued at $1,112.95 to DMS Pharmaceutical Group Inc., a woman-owned small business based in Park Ridge, Illinois. The contract is for the delivery of varicella virus vaccine (SPE2D021D0004|SPE2D024F0535) and has an ultimate completion date of September 16, 2024. DMS Pharmaceutical Group is a key supplier in the federal pharmaceutical supply chain, providing a wide range of branded and...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $1,112.95 fixed-price with economic price adjustment contract is for the delivery of varicella virus vaccine, with a period of performance running through July 1, 2024. DMS Pharmaceutical Group holds a larger indefinite delivery contract (IDC) with the DLA, valued at up to $499,999,999, which allows...
The U.S. government agency Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract valued at $2,080.44 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract, with a completion date of February 13, 2024, is for the delivery of VARIVAX vaccine with diluents to support the medical supply needs of military health facilities. DMS Pharmaceutical Group Inc. also holds a larger Indefinite Delivery...
This federal contract award is for the delivery of VARIVAX vaccine with diluents to the Defense Logistics Agency (DLA), a defense agency. The $16,643.52 firm fixed-price delivery order was awarded to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract has an ultimate completion date of February 14, 2024 and is not associated with any set-aside designations. DMS Pharmaceutical Group Inc. holds a $499,999,999...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $1,112.95 contract is for the delivery of varicella virus vaccine (8510842339) and has a ceiling value of $1,112.95. The contract is not associated with any set-aside designation. DMS Pharmaceutical Group Inc. holds a $499,999,999 Indefinite Delivery Contract (IDC) with the...
This contract award, valued at $1,112.95, is for the delivery of VARIVAX vaccine with diluent to the U.S. Defense Logistics Agency (DLA) under the Medical Supply Chain division. The prime contractor is DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. This contract is a firm fixed-price delivery order and does not have a set-aside designation. DMS Pharmaceutical Group Inc. holds a significant indefinite delivery contract (IDC)...
This federal contract award was issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract is a delivery order valued at $4,160.88 for the supply of the VARIVAX vaccine with diluents. It is a firm fixed-price contract with no set-aside designation. The contract is part of a larger indefinite delivery contract (IDC) with the DLA under the SPE2DB program, valued at up to...
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract worth $6,241.32 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler located in Park Ridge, Illinois. The contract is for the delivery of VARIVAX vaccine with diluents to support the medical supply needs of military healthcare facilities. This delivery order contract is part of a larger $499,999,999 Indefinite Delivery Contract (IDC) held by DMS Pharmaceutical Group with...
The U.S. Defense Logistics Agency Troop Support Medical awarded a firm fixed-price delivery order valued at $3,121.08 to DMS Pharmaceutical Group Inc., a woman-owned small business located in Park Ridge, Illinois. The order is for the supply of the VARIVAX vaccine with diluents. DMS Pharmaceutical Group holds an Indefinite Delivery Contract (IDC) with the Defense Logistics Agency, contract 4600082013 under the SPE2DB program, valued up to $4,999,999 through 2025. This IDC allows the DLA to issue...
  • SPE2D021D0004
    Indefinite Delivery Contract
  • SPE2D021D0004-SPE2D024F0368
    Delivery Order

This federal contract award, with ID SPE2D021D0004|SPE2D024F0368, was issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The award is for the delivery of varicella virus vaccines, with a total ceiling value of $1,112.95.

The contract is a firm fixed-price delivery order with economic price adjustment, and has an ultimate completion date of March 5, 2025. DMS Pharmaceutical Group Inc. holds a significant single-award Indefinite Delivery Contract (IDC) with the DLA under the SPE2DB program, valued at $499,999,999 and valid through November 2026. This IDC enables the DLA to issue firm fixed-price delivery orders for a comprehensive range of pharmaceutical items to support the medical supply needs of military health facilities worldwide. The contract does not have a set-aside designation.

Generated 7/1/25, 6:18 AM